1 Department of Neurology and Stroke Center, Neuroscience and Cerebrovascular Research Laboratory, La Paz University Hospital, Neuroscience Area of IdiPAZ Health Research Institute, Autonomous University of Madrid, Madrid, Spain.
2 Cardiovascular Proteomics Laboratory & Proteomics Unit, National Center for Cardiovascular Research, CNIC, Madrid, Spain.
J Cereb Blood Flow Metab. 2018 May;38(5):767-779. doi: 10.1177/0271678X17708917. Epub 2017 May 19.
Exosomes are gaining importance because they show great promise in therapeutic applications for several diseases. Particularly in stroke, exosomes derived from mesenchymal stem cell (MSC) therapy work as paracrine effectors responsible for promoting neurovascular remodeling and functional recovery. Adult male rats were subjected to intracerebral hemorrhage (ICH) by intrastriatal injection of collagenase type IV; 24 h after surgery, MSC-derived exosomes were administered through the tail vein. The rats were euthanized at 7 or 28 days after treatment. Functional evaluation, lesion size, fiber tract integrity, axonal sprouting and white matter repair markers, biodistribution of exosomes and secretome proteomics were analyzed. DiI-labeled exosomes were found in the brains of the ICH-treated group and in the liver, lung and spleen. Animals receiving treatment with exosomes showed significantly better results in terms of functional recovery, lesion size, fiber tract integrity, axonal sprouting and white matter repair markers compared with the control group 28 days after stroke. Proteomics analysis of the exosomes identified more than 2000 proteins that could be implicated in brain repair function. In conclusion, white matter integrity was partly restored by exosome administration mediated by molecular repair factors. Exosomes as a treatment could be a heterogeneous process by nature and presents many factors that can influence brain plasticity in an adaptable and versatile manner.
外泌体的重要性日益凸显,因为它们在多种疾病的治疗应用中具有巨大的应用前景。特别是在中风中,来源于间充质干细胞 (MSC) 治疗的外泌体作为旁分泌效应物,负责促进神经血管重塑和功能恢复。雄性成年大鼠通过纹状体注射 IV 型胶原酶诱导脑内出血 (ICH);手术后 24 小时,通过尾静脉给予 MSC 来源的外泌体。在治疗后 7 或 28 天处死大鼠。进行功能评估、损伤大小、纤维束完整性、轴突发芽和白质修复标志物、外泌体的生物分布和分泌组蛋白质组学分析。DiI 标记的外泌体在 ICH 治疗组的大脑中以及肝脏、肺和脾脏中被发现。与对照组相比,接受外泌体治疗的动物在中风后 28 天,在功能恢复、损伤大小、纤维束完整性、轴突发芽和白质修复标志物方面的结果显著更好。对外泌体的蛋白质组学分析鉴定出 2000 多种可能与脑修复功能相关的蛋白质。总之,通过分子修复因子介导的外泌体给药部分恢复了白质完整性。外泌体作为一种治疗方法,其本质上可能是一种异质过程,并以灵活多变的方式呈现出许多能够影响大脑可塑性的因素。